Metoclopramide‐induced tardive dyskinesia in an infant
Identifieur interne : 004F34 ( Main/Merge ); précédent : 004F33; suivant : 004F35Metoclopramide‐induced tardive dyskinesia in an infant
Auteurs : Nicte I. Mejia [États-Unis] ; Joseph Jankovic [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-01.
English descriptors
- KwdEn :
- Adolescent, Child, Child, Preschool, Demography, Dopamine Antagonists, Dyskinesia, Drug-Induced (etiology), Female, Gastroesophageal Reflux (drug therapy), Humans, Infant, Male, Metoclopramide (adverse effects), Stereotyped Behavior (physiology), Tardive dyskinesia, children, infant, metoclopramide, neuroleptic drugs.
- MESH :
- chemical , adverse effects : Metoclopramide.
- chemical : Dopamine Antagonists.
- drug therapy : Gastroesophageal Reflux.
- etiology : Dyskinesia, Drug-Induced.
- physiology : Stereotyped Behavior.
- Adolescent, Child, Child, Preschool, Demography, Female, Humans, Infant, Male.
Abstract
We describe a 1‐year‐old girl who developed orofaciolingual stereotypy at age 2 months after a 17‐day treatment with metoclopramide for gastroesophageal reflux. The stereotypy, documented by sequential videos, persisted for at least 9 months after the drug was discontinued. This patient represents the first documented case of tardive dyskinesia in an infant. We also review previous reports of tardive dyskinesia in children. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20259
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003288
- to stream Istex, to step Curation: 003288
- to stream Istex, to step Checkpoint: 002257
- to stream PubMed, to step Corpus: 003265
- to stream PubMed, to step Curation: 003265
- to stream PubMed, to step Checkpoint: 003062
- to stream Ncbi, to step Merge: 001023
- to stream Ncbi, to step Curation: 001023
- to stream Ncbi, to step Checkpoint: 001023
Links to Exploration step
ISTEX:049B9E39949F0D57386B1869EF9096E9651CA8FFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metoclopramide‐induced tardive dyskinesia in an infant</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I." last="Mejia">Nicte I. Mejia</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:049B9E39949F0D57386B1869EF9096E9651CA8FF</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20259</idno>
<idno type="url">https://api.istex.fr/document/049B9E39949F0D57386B1869EF9096E9651CA8FF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003288</idno>
<idno type="wicri:Area/Istex/Curation">003288</idno>
<idno type="wicri:Area/Istex/Checkpoint">002257</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Mejia N:metoclopramide:induced:tardive</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15390048</idno>
<idno type="wicri:Area/PubMed/Corpus">003265</idno>
<idno type="wicri:Area/PubMed/Curation">003265</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003062</idno>
<idno type="wicri:Area/Ncbi/Merge">001023</idno>
<idno type="wicri:Area/Ncbi/Curation">001023</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001023</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Mejia N:metoclopramide:induced:tardive</idno>
<idno type="wicri:Area/Main/Merge">004F34</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Metoclopramide‐induced tardive dyskinesia in an infant</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I." last="Mejia">Nicte I. Mejia</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-01">2005-01</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="86">86</biblScope>
<biblScope unit="page" to="89">89</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">049B9E39949F0D57386B1869EF9096E9651CA8FF</idno>
<idno type="DOI">10.1002/mds.20259</idno>
<idno type="ArticleID">MDS20259</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Demography</term>
<term>Dopamine Antagonists</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Gastroesophageal Reflux (drug therapy)</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Metoclopramide (adverse effects)</term>
<term>Stereotyped Behavior (physiology)</term>
<term>Tardive dyskinesia</term>
<term>children</term>
<term>infant</term>
<term>metoclopramide</term>
<term>neuroleptic drugs</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Metoclopramide</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dopamine Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Gastroesophageal Reflux</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stereotyped Behavior</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Demography</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We describe a 1‐year‐old girl who developed orofaciolingual stereotypy at age 2 months after a 17‐day treatment with metoclopramide for gastroesophageal reflux. The stereotypy, documented by sequential videos, persisted for at least 9 months after the drug was discontinued. This patient represents the first documented case of tardive dyskinesia in an infant. We also review previous reports of tardive dyskinesia in children. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.20259"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metoclopramide‐induced tardive dyskinesia in an infant</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I." last="Mejia">Nicte I. Mejia</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:049B9E39949F0D57386B1869EF9096E9651CA8FF</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20259</idno>
<idno type="url">https://api.istex.fr/document/049B9E39949F0D57386B1869EF9096E9651CA8FF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003288</idno>
<idno type="wicri:Area/Istex/Curation">003288</idno>
<idno type="wicri:Area/Istex/Checkpoint">002257</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Mejia N:metoclopramide:induced:tardive</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Metoclopramide‐induced tardive dyskinesia in an infant</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I." last="Mejia">Nicte I. Mejia</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-01">2005-01</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="86">86</biblScope>
<biblScope unit="page" to="89">89</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">049B9E39949F0D57386B1869EF9096E9651CA8FF</idno>
<idno type="DOI">10.1002/mds.20259</idno>
<idno type="ArticleID">MDS20259</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Tardive dyskinesia</term>
<term>children</term>
<term>infant</term>
<term>metoclopramide</term>
<term>neuroleptic drugs</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We describe a 1‐year‐old girl who developed orofaciolingual stereotypy at age 2 months after a 17‐day treatment with metoclopramide for gastroesophageal reflux. The stereotypy, documented by sequential videos, persisted for at least 9 months after the drug was discontinued. This patient represents the first documented case of tardive dyskinesia in an infant. We also review previous reports of tardive dyskinesia in children. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metoclopramide-induced tardive dyskinesia in an infant.</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I" last="Mejia">Nicte I. Mejia</name>
<affiliation wicri:level="1"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea>
<wicri:noRegion>Texas 77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15390048</idno>
<idno type="pmid">15390048</idno>
<idno type="doi">10.1002/mds.20259</idno>
<idno type="wicri:Area/PubMed/Corpus">003265</idno>
<idno type="wicri:Area/PubMed/Curation">003265</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003062</idno>
<idno type="wicri:Area/Ncbi/Merge">001023</idno>
<idno type="wicri:Area/Ncbi/Curation">001023</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001023</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Mejia N:metoclopramide:induced:tardive</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Metoclopramide-induced tardive dyskinesia in an infant.</title>
<author><name sortKey="Mejia, Nicte I" sort="Mejia, Nicte I" uniqKey="Mejia N" first="Nicte I" last="Mejia">Nicte I. Mejia</name>
<affiliation wicri:level="1"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea>
<wicri:noRegion>Texas 77030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Demography</term>
<term>Dopamine Antagonists</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Gastroesophageal Reflux (drug therapy)</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Metoclopramide (adverse effects)</term>
<term>Stereotyped Behavior (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Metoclopramide</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dopamine Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Gastroesophageal Reflux</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stereotyped Behavior</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Demography</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We describe a 1-year-old girl who developed orofaciolingual stereotypy at age 2 months after a 17-day treatment with metoclopramide for gastroesophageal reflux. The stereotypy, documented by sequential videos, persisted for at least 9 months after the drug was discontinued. This patient represents the first documented case of tardive dyskinesia in an infant. We also review previous reports of tardive dyskinesia in children.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004F34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:049B9E39949F0D57386B1869EF9096E9651CA8FF |texte= Metoclopramide‐induced tardive dyskinesia in an infant }}
This area was generated with Dilib version V0.6.23. |